"The Medical Letter content has long been recognized as quality drug information, free of industry bias. Since 1959, it has been providing physicians and other healthcare professionals with objective drug information to help them prescribe what is truly in the best interest of their patients." said Yosef Wissner-Levy, Publisher. "This partnership benefits the more than 30,000 healthcare professionals who utilize NewCrop’s best-in-class e-prescribing, and EHRs that work with NewCrop."
NewCrop users now have immediate access to objective and peer-reviewed evaluations of new FDA-approved drugs, and unbiased reviews of drug classes used to treat common disorders. “NewCrop focuses on providing solutions and information to help providers and patients by providing valuable programs and information. The solutions are offered through a network of over 170 EHR partners. NewCrop is excited to add The Medical Letter to our list of offerings”, said Lawrence Susnow, M.D., President and Co-Founder of NewCrop., “The Medical Letter has, for my many years of clinical practice, been the primary source for comprehensive and objective drug information. I am pleased to be able to now present this high-quality information precisely where and when it is of most value, as drugs are being selected and prescribed.”
The Medical Letter is pleased to have its content included and utilized in the field of ePrescribing. Being an integral part of EHRs allows The Medical Letter to contribute to patient safety on an even larger scale by providing valuable information at the point of care.
Director Marketing & Communications
The Medical Letter Inc.
145 Huguenot St., Suite 312
New Rochelle, NY 10801
Phone: 914.235.0500 Ext. 345
joanne@medicalletter.org
Randy Barnes
Vice President, Business Development
NewCrop
1800 Bering Dr. #600
Houston, Texas77057
Phone: 541.318.1027
rbarnes@newcroprx.com